These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38126073)

  • 1. Unveiling patenting strategies of therapeutics and vaccines: evergreening in the context of COVID-19 pandemic.
    Bacigalupo ML; Pignataro MF; Scopel CT; Kondratyuk S; Mellouk O; Chaves GC
    Front Med (Lausanne); 2023; 10():1287542. PubMed ID: 38126073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Linkage' pharmaceutical evergreening in Canada and Australia.
    Faunce TA; Lexchin J
    Aust New Zealand Health Policy; 2007 Jun; 4():8. PubMed ID: 17543113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Patent "Evergreening" Restricting Access to Medicine/Device Combination Products?
    Beall RF; Nickerson JW; Kaplan WA; Attaran A
    PLoS One; 2016; 11(2):e0148939. PubMed ID: 26910128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovations and development of Covid-19 vaccines: A patent review.
    Alshrari AS; Hudu SA; Imran M; Asdaq SMB; Ali AM; Rabbani SI
    J Infect Public Health; 2022 Jan; 15(1):123-131. PubMed ID: 34742639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research.
    Musyuni P; Aggarwal G; Nagpal M; Goyal RK
    Curr Pharm Des; 2021; 27(3):423-439. PubMed ID: 32693757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patents associated with high-cost drugs in Australia.
    Christie AF; Dent C; McIntyre P; Wilson L; Studdert DM
    PLoS One; 2013; 8(4):e60812. PubMed ID: 23577165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Economic Theory of Patent Protection and Pandemic Influenza Vaccines: Do Patents Really Incentivize Innovation in the Field?
    Eccleston-Turner M
    Am J Law Med; 2016 May; 42(2-3):572-597. PubMed ID: 29086638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What future for the pharmaceutical patenting in europe: reforming or getting rid of it?].
    Badinella Martini M; Nobili A; Garattini L
    Recenti Prog Med; 2022 Mar; 113(3):157-160. PubMed ID: 35315444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evergreened drugs or evergreened profits?
    Siddalingaiah S; Fugh-Berman A
    J Eval Clin Pract; 2022 Dec; 28(6):1119-1126. PubMed ID: 35543377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herbal drug patenting in India: IP potential.
    Sahoo N; Manchikanti P; Dey SH
    J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategic Patenting by Pharmaceutical Companies - Should Competition Law Intervene?
    Gurgula O
    IIC Int Rev Ind Prop Copyr Law; 2020; 51(9):1062-1085. PubMed ID: 33132411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evergreening of Psychiatric Medications: A Systemic Literature Review of Strategies, Case Examples, and the Implications of Cost.
    Andrade JKL; Fujimoto CJ; Hishinuma ES; Miyamoto IA; Agapoff JA; Kracher SL; Takeshita J; China CO
    Community Ment Health J; 2023 Apr; 59(3):451-458. PubMed ID: 36094749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Information Disclosed in Patent Documents being the Source to Address Emergencies: A Strategy to Achieve Technological Developments Addressing COVID-19.
    Martins TD; Cordeiro DS
    Recent Pat Biotechnol; 2021 Oct; 15(2):148-163. PubMed ID: 33797389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving clinical equality in an influenza pandemic: patent realities.
    Kane EM
    Seton Hall Law Rev; 2009; 39(4):1137-72. PubMed ID: 20718133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding 'Evergreening': Making Minor Modifications Of Existing Medications To Extend Protections.
    Feldman R
    Health Aff (Millwood); 2022 Jun; 41(6):801-804. PubMed ID: 35579932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent "Evergreening" of Medicine-Device Combination Products: A Global Perspective.
    Beall RF; Glazer T; Ahmad H; Buell M; Hahn S; Houston AR; Kesselheim AS; Nickerson JW; Kaplan W
    Healthc Policy; 2022 Oct; 18(2):14-26. PubMed ID: 36495532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. India: Court upholds patent law denying patents for slightly modified versions of existing drugs.
    Swamy M
    HIV AIDS Policy Law Rev; 2007 Dec; 12(2-3):50-1. PubMed ID: 18459215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are the UK courts clamping down on 'evergreening' strategies for the extension of patent protection?
    Albutt J
    Pharm Pat Anal; 2015 Jan; 4(1):1-3. PubMed ID: 25565154
    [No Abstract]   [Full Text] [Related]  

  • 20. The patent maze of COVID 19 vaccines.
    Storz U
    Expert Opin Ther Pat; 2021 Dec; 31(12):1177-1188. PubMed ID: 34139951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.